Company: INGN
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001193125-25-269484
Chunk: 1

Company: Inogen Inc
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 1
---
099

     16,594

     Deferred revenue - noncurrent
      
     4,081

     5,747

     Deferred tax liability
      
     7,894

     6,948

     Total liabilities
      
     109,834

     122,325

     Commitments and contingencies (Note 9)

     Stockholders' equity

     Common stock, $0.001 par value per share; 200,000,000 shares authorized; 27,148,482 and 23,902,338 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively
      
     27

     24

     Additional paid-in capital
      
     361,921

     328,174

     Accumulated deficit
      
     (168,457
     )

     (152,837
     )

     Accumulated other comprehensive income (loss)
      
     3,684

     (1,501
     )

     Total stockholders' equity
      
     197,175

     173,860

     Total liabilities and stockholders' equity
     $
     307,009

     $
     296,185

See accompanying condensed notes to the consolidated financial statements.